GynTect

Schnell zu einer sicheren Diagnose

Die Neuheit für Diagnostiklabore

GynTect.

GynTect.

Sichere Diagnose

Sie haben Fragen zu GynTect?

Wir helfen weiter!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

News

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

cobas Z480 Analyzer von Roche Diagnostics oncgnostics GmbH

Early detection test GynTect® now available for Roche Diagnostics QPCR system

Jena, 20. February, 2019 – The test for early detection of cervical cancer GynTect® may now also be performed on the cobas Z480 analyzer, a widely used quantitative PCR (QPCR) system from Roche Diagnostics. This is now possible through an…
cobas Z480 Analyzer von Roche Diagnostics oncgnostics GmbH

Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018

,
Oncgnostics will discuss new clinical data with gynaecological key opinion leaders at EUROGIN 2018 SAN FRANCISCO, CA, USA, November 29, 2018 -- Oncgnostics GmbH presents new clinical data on GynTect® Precision Diagnostics for triage of…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.